COVID-19: Here's Number Of Americans Who've Become Infected Despite Being Vaccinated, CDC Says COVID-19: Here's Number Of Americans Who've Become Infected Despite Being Vaccinated, CDC Says
Covid-19: Here's Number Of Americans Who've Become Infected Despite Being Vaccinated, CDC Says The Centers for Disease Control & Prevention (CDC) has released the first data on so-called "breakthrough" COVID-19 cases, meaning those who have become infected despite being fully vaccinated. So far, there have been about 5,800 such cases, the CDC told CNN.  At the time that data was collected, 77 million American adults had been fully vaccinated, meaning 99.992 percent had dodged the disease. The efficacy rates of the double-dose Pfizer and Moderna vaccines are both around 95 percent. "To date, no unexpected patterns have been identified in case demographics or vaccine ch…
COVID-19: Side Effects Are More Likely After Second Pfizer Or Moderna Dose; Here's Why COVID-19: Side Effects Are More Likely After Second Pfizer Or Moderna Dose; Here's Why
Covid-19: Side Effects Are More Likely After Second Pfizer Or Moderna Dose; Here's Why Feeling a bit sleepy, sore, and achy after getting your COVID-19 vaccine? Don't fret. Side effects are a sign that the body's immune system is responding to the dose, and that it's working, according to medical experts.  One of them, Dr.Allison Arwady, the Chicago Department of Public Health Commissioner, said younger people are more likely to experience side effects because they "have more robust immune system broadly," according to a report by NBC 5 Chicago. Women are also more likely to report side effects than men, Arwady said, noting estrogen can elevate immune response…
COVID-19: Moderna Seeks Full FDA Approval For Vaccine COVID-19: Moderna Seeks Full FDA Approval For Vaccine
Covid-19: Moderna Seeks Full FDA Approval For Vaccine With six months having passed since Moderna began clinical trials for its COVID-19 vaccine, the pharmaceutical company is seeking full approval from the Food and Drug Administration. Moderna, which currently has emergency use authorization from the FDA to distribute its vaccine, reported in its latest trial data that it has proven 90 percent effective in preventing the symptoms of COVID-19, and 95 percent effective in the most severe cases of the virus. Currently, no COVID-19 vaccine is fully approved by the FDA, but three - Moderna, Pfizer, and the currently questionable Johnson & John…
COVID-19 Combo Pack: Mixup Leads To Man Getting One Dose Each Of Moderna, Pfizer Vaccines COVID-19 Combo Pack: Mixup Leads To Man Getting One Dose Each Of Moderna, Pfizer Vaccines
Covid-19 Combo Pack: Mixup Leads To Man Getting One Dose Each Of Moderna, Pfizer Vaccines Call it a COVID-19 combo pack. A New England man is telling his story after a mixup led to him getting one dose each of the Moderna and Pfizer COVID-19 vaccines. New Hampshire resident Craig Richards quickly noticed on Tuesday, April 13 that the second dose he had just received was a Pfizer shot. His first dose had been the Moderna vaccine. "As soon as he poked me, he looked down at my card, and I think he realized he just gave me the Pfizer," Richards told ABC-TV affiliated WMUR of Manchester, New Hampshire. A supervisor at the site, the same place Richards received his first dose, …
COVID-19: New Study Reveals How Prevalent Blood Clots Are With Pfizer, Moderna Vaccines COVID-19: New Study Reveals How Prevalent Blood Clots Are With Pfizer, Moderna Vaccines
Covid-19: New Study Reveals How Prevalent Blood Clots Are With Pfizer, Moderna Vaccines The ratio of people who have suffered from blood clots after receiving the Moderna or Pfizer COVID-19 vaccine is approximately the same as those who receive the AstraZeneca vaccine, according to a new study. Oxford University researchers found that the number of people who receive blood clots after getting vaccinated is approximately the same for all three vaccines, with four in one million people experiencing cerebral venous thrombosis (CVT) after getting the Pfizer or Moderna vaccine, compared to five in one million people for the AstraZeneca vaccine. The new study comes in the wake of A…
COVID-19: Pfizer CEO Reveals When Vaccine Booster Shot Likely Will Be Needed After Second Dose COVID-19: Pfizer CEO Reveals When Vaccine Booster Shot Likely Will Be Needed After Second Dose
Covid-19: Pfizer CEO Reveals When Vaccine Booster Shot Likely Will Be Needed After Second Dose Pfizer CEO Albert Bourla is cautioning that patients will likely need a third dose of the company’s COVID-19 vaccine within the next year to maintain the shot’s efficacy. During a recently aired interview, Bourla said that patients will “likely” need an additional dose of the vaccine within 12 months of becoming fully vaccinated with the two required doses. Bourla said that they are continuing to monitor the situation, and as more COVID-19 variants arise, the company may be forced to shift gears. “We need to see what would be the sequence, and for how often we need to do that, that remains…
COVID-19: Moderna Announces When Booster Shot Will Be Available For Those Who Got Two Doses COVID-19: Moderna Announces When Booster Shot Will Be Available For Those Who Got Two Doses
Covid-19: Moderna Announces When Booster Shot Will Be Available For Those Who Got Two Doses Moderna is working on a booster shot for its two-dose COVID-19 vaccine that will be made available by the fall to help avoid another surge of new cases over the winter. CEO Stephane Bancel said on CNBC that the company “wants to make sure there are boost vaccines available in the fall so that we protect people as we go into the next fall and winter season in the U.S.” Last month, the National Institutes of Health began testing several versions of boosters from Moderna that could potentially be used to combat variants of COVID-19, including the South African strain that has flummoxed resear…
COVID-19: NY Woman Tests Positive One Month After Getting Second Vaccine Dose COVID-19: NY Woman Tests Positive One Month After Getting Second Vaccine Dose
Covid-19: NY Woman Tests Positive One Month After Getting Second Vaccine Dose A New York woman who was fully vaccinated for COVID-19 tested positive a month after receiving her second dose. Melanie Rosen, who lives in Valley Stream on Long Island, received her second dose of the Moderna COVID-19 vaccine in Queens on Saturday, Feb. 20, but it wasn’t enough to keep her from contracting the virus for a second time last month. According to multiple reports, including PIX 11, Rosen was so confident in the vaccine that she willingly went to visit with a group of friends without wearing a mask, although they were not vaccinated. While it hasn’t been confirmed that she cau…
COVID-19: Did You Get Now-Paused J&J Vaccine? These Are Rare Symptoms To Watch For, CDC Says COVID-19: Did You Get Now-Paused J&J Vaccine? These Are Rare Symptoms To Watch For, CDC Says
Covid-19: Did You Get Now-Paused J&J Vaccine? These Are Rare Symptoms To Watch For, CDC Says The one-dose Johnson & Johnson COVID-19 vaccine has proven efficient in getting the needles in as many Americans’ arms as possible, but some are reporting debilitating side effects after receiving their shot. Recently, some have come forward with severe symptoms after being administered the COVID-19 vaccine, prompting some health officials to issue warnings and the FDA to press pause on distributing new allocations to pharmacies and healthcare providers across the country. Earlier story - CDC, FDA Call For Pause On Johnson & Johnson Vaccine Symptoms include a severe, persisting hea…
COVID-19: Brand-New Trial Reveals Moderna Vaccine's Effectiveness After Six Months COVID-19: Brand-New Trial Reveals Moderna Vaccine's Effectiveness After Six Months
Covid-19: Brand-New Trial Reveals Moderna Vaccine's Effectiveness After Six Months The Moderna COVID-19 vaccine loses a bit of its effectiveness after six months, though not as much as originally thought, according to the latest trial conducted by the pharmaceutical company. Moderna found in its latest trial that its COVID-19 vaccine maintains at least 90 percent of its efficacy in battling the virus after six months. Related story - COVID:19: COVID-19: Brand-New Study Compares Side Effects Of Pfizer, Moderna Vaccine Recipients Researchers said the latest data evaluated 33 adults who participated in Phase 1 of Moderna’s vaccine study, which found the antibodies pers…
COVID-19: Pfizer Dramatically Ramps Up Distribution After Pause On Johnson & Johnson Vaccines COVID-19: Pfizer Dramatically Ramps Up Distribution After Pause On Johnson & Johnson Vaccines
Covid-19: Pfizer Dramatically Ramps Up Distribution After Pause On Johnson & Johnson Vaccines Hundreds of millions of new COVID-19 vaccines are set to be distributed across the country as Pfizer prepares to ramp up the production of its doses amid the pause of the Johnson & Johnson one-dose shot rollout. Pfizer CEO Albert Bourla announced that his company, with headquarters in the New York (in Manhattan and Rockland County), is now on track to deliver 10 percent more vaccine doses to the US (approximately 220 million) while supplying the already agreed upon 300 million doses for the end of July two weeks early. Both Pfizer and Moderna, two of the three approved vaccines by the F…
COVID-19: Vaccine Rivalry? Comparisons Between Moderna, Pfizer Doses Can Get Heated COVID-19: Vaccine Rivalry? Comparisons Between Moderna, Pfizer Doses Can Get Heated
Covid-19: Vaccine Rivalry? Comparisons Between Moderna, Pfizer Doses Can Get Heated Are you Team Moderna or Team Pfizer? A good-natured rivalry has been brewing between those receiving the Moderna COVID-19 vaccine versus the Pfizer vaccine as more doses have been made available to the majority of the public. Since Americans began receiving their initial doses of the two-shot Moderna and Pfizer vaccines, photos of vaccination cards and celebratory videos of successful shots have flooded social media, with some on both sides taking playful jabs at the other in the process. Related story - COVID:19: COVID-19: Brand-New Study Compares Side Effects Of Pfizer, Moderna Va…